Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - OPERATING EXPENSES
Operating Expenses FDMT - 4D Molecular Therapeutics, Inc.
134 M
LAST VALUE
22.26%
2 YEAR CAGR
40.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR